Historical Stock Price
ETFs Holding ABIO »    ABIO Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
01/23/2023 $2.27 $2.30 $2.25 $2.29 24.10K
01/24/2023 $2.25 $2.31 $2.25 $2.27 33.00K
01/25/2023 $2.24 $2.30 $2.23 $2.30 32.30K
01/26/2023 $2.33 $2.39 $2.24 $2.27 23.00K
01/27/2023 $2.31 $2.31 $2.18 $2.22 40.10K
ARCA biopharma is a clinical-stage biopharmaceutical company. Co.'s primary product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2 (AB201)) as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro™ (bucindolol hydrochloride) for the treatment of atrial fibrillation in patients with chronic heart failure. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy.
ABIO historical stock prices picture
ARCA biopharma (ABIO) has the following price history information. Looking back at ABIO historical stock prices for the last five trading days, on January 23, 2023, ABIO opened at $2.27, traded as high as $2.30 and as low as $2.25, and closed at $2.29. Trading volume was a total of 24.10K shares. On January 24, 2023, ABIO opened at $2.25, traded as high as $2.31 and as low as $2.25, and closed at $2.27. Trading volume was a total of 33.00K shares. On January 25, 2023, ABIO opened at $2.24, traded as high as $2.30 and as low as $2.23, and closed at $2.30. Trading volume was a total of 32.30K shares. On January 26, 2023, ABIO opened at $2.33, traded as high as $2.39 and as low as $2.24, and closed at $2.27. Trading volume was a total of 23.00K shares. On January 27, 2023, ABIO opened at $2.31, traded as high as $2.31 and as low as $2.18, and closed at $2.22. Trading volume was a total of 40.10K shares.

ABIO Historical Stock Prices By Date:

ABIO historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into ARCA biopharma shares, starting with a $10,000 purchase of ABIO, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 01/30/2013
End date: 01/27/2023
Start price/share: $514.08
End price/share: $2.22
Dividends collected/share: $0.00
Total return: -99.57%
Average Annual Total Return: -41.99%
Starting investment: $10,000.00
Ending investment: $43.22
Years: 10.00
Date Close
01/23/2023$2.29
01/24/2023$2.27
01/25/2023$2.30
01/26/2023$2.27
01/27/2023$2.22
ABIO is categorized under the Healthcare sector; below are some other companies in the same sector:

ABMD Historical Stock Prices
ABOS Historical Stock Prices
ABSI Historical Stock Prices
ABT Historical Stock Prices
ABV Historical Stock Prices
ABVC Historical Stock Prices
ACAD Historical Stock Prices
ACCD Historical Stock Prices
ACER Historical Stock Prices
ACET Historical Stock Prices

Also explore: ABIO shares outstanding history

Email EnvelopeFree ABIO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

ABIO Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2023, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.